MMRF - unentdeckte Perle vor dem Turnaround

Ticker: MMRF
Kurs: $0.0368
Börse: OTCBB
Typ of Play: Turnaround
Webseite: www.mmrglobal.com/
a/s: 650,000,000
o/s: 336,286,196 As of October 17, 2011
MMRF insider trades:
www.secform4.com/insider-trading/1285701.htm
ih.advfn.com/...NB%5EMMRF&p=0&t=23&dm=0&vol=1" style="max-width:560px" />
stockcharts.com/c-sc/...mp;dy=0&i=p09977663964&r=5473" style="max-width:560px" />
stockcharts.com/c-sc/...mp;dy=0&i=p01903309815&r=2659" style="max-width:560px" />
stockcharts.com/c-sc/...mp;dy=0&i=p80281532549&r=4749" style="max-width:560px" />
stockcharts.com/c-sc/...amp;g=0&i=p27644565879&r=1598" style="max-width:560px" />

MMRGlobal Schedules Shareholder Chat Tuesday, November 29, 2011, 1:15 p.m. PT

MMRGlobal, Inc. (OTCBB: MMRF), a leading provider of Personal Health Records (www.mmrvideos.com), MyEsafeDepositBox storage solutions (www.myesafevideos.com) and electronic document management and imaging systems for healthcare professionals (www.mmrprovideos.com), today announced it will host a shareholder "Chat," scheduled for Tuesday, November 29, 2011, at 1:15 p.m. Pacific Time/4:15 p.m. Eastern Time. Robert H. Lorsch, Chairman and Chief Executive Officer, and Ingrid Safranek, Chief Financial Officer, will discuss recent announcements and transactions the Company has made and answer questions from stockholders.

"There is nothing more exciting in today's financial markets than what is going on in healthcare and specifically Health IT," said CFO Ingrid Safranek. "That's why we are inviting you to learn about how the future of healthcare is at work today at MMR. This will give you an opportunity to get an update from management and ask any questions you may have." Although there will be a live Q&A session on the call, the Company is encouraging shareholders and other interested parties to submit questions in advance to info@mmrmail.com to make sure all the questions are answered in an expedient manner.

MMR will answer questions about several of the Company's recent announcements, including its relationship with UST Global®, a leading provider of end-to-end IT services and solutions for Global 1000 companies. UST is working with MMRGlobal to sell the Company's MyMedicalRecords Personal Health Record and MMRPro document management and imaging system(s) and integrate them with existing and new UST clients.

The Company will also discuss the ng Connect Program, a multi-industry open innovation program founded by Alcatel-Lucent that includes more than 80 members. This includes MMR's participation with ng Connect at the 2012 Consumer Electronics Show being held January 10-13, at the Las Vegas Convention Center, Booth #31412 in the South Upper Hall.

The Company will also answer questions about recent developments regarding its legacy biotech assets and legal settlements resulting in the transfer to MMR of thousands of patient tissue samples and other intellectual property that may be worth millions of dollars in future revenue, and questions about its evolving relationship with JERCS, Inc.

The Company also revealed that MMR Spokesperson Kira Reed will be hosting the Red Carpet at the 80th annual Hollywood Christmas Parade, November 27, 2011, which will be broadcast nationwide on the Hallmark Channel throughout December.

The conference call will be broadcast live over the Internet at phx.corporate-ir.net/...tails&c=178404&eventID=4250082 or by linking to Investor Relations at www.mmrglobal.com. You will need to register 15 minutes prior to the start of the call. The call may also be accessed by calling (866)730-5768. Participants should use Passcode 89782329.

About MMRGlobal, Inc.

MMRGlobal, Inc., through its wholly-owned operating subsidiary, MyMedicalRecords, Inc. ("MMR") (www.mymedicalrecords.com), provides secure and easy-to-use online Personal Health Records ("PHRs") and electronic safe deposit box storage solutions, serving consumers, healthcare professionals, employers, insurance companies, financial institutions, and professional organizations and affinity groups. MyMedicalRecords enables individuals and families to access their medical records and other important documents, such as birth certificates, passports, insurance policies and wills, anytime from anywhere using the Internet. The MyMedicalRecords Personal Health Record is built on proprietary, patented technologies to allow documents, images and voicemail messages to be transmitted and stored in the system using a variety of methods, including fax, phone, or file upload without relying on any specific electronic medical record platform to populate a user's account. The Company's professional offering, MMRPro, is designed to give physicians' offices an easy and cost-effective solution to digitizing paper-based medical records and sharing them with patients in real time through an integrated patient portal. MMR is an Independent Software Vendor Partner with Kodak to deliver an integrated turnkey EMR solution for healthcare professionals. Through its merger with Favrille, Inc. in January 2009, the Company acquired intellectual property biotech assets that include anti-CD20 antibodies and data and samples from its FavId™/Specifid™ vaccine clinical trials for the treatment of B-Cell Non-Hodgkin's lymphoma. To learn more about MMRGlobal, Inc. and its products, visit www.mmrglobal.com.

Forward-Looking Statements

Statements in this press release that are not strictly historical in nature, including future performance, management's expectations, beliefs, intentions, estimates or projections, constitute "forward-looking statements." Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the Company's actual results to be materially different from historical results or from any results expressed or implied by such forward-looking statements. Some can be identified by the use of words (and their derivations) such as "need," "possibility," "offer," "development," "if," "negotiate," "when," "begun," "believe," "achieve," "will," "estimate," "expect," "could," "maintain," "plan," "may," and "continue," or the negative of these words. Factors that could cause or contribute to such differences include, but are not limited to, the evolving relationship between the Company and JERCS, Inc.; the risk the Company's products are not adopted or viewed favorably by the healthcare community; risks related to the current uncertainty and instability in financial and lending markets, including global economic uncertainties; variations in our quarterly operating results; litigation matters; product integration in physician practices, surgery centers and hospitals; timing and volume of sales and installations, including MMRPro; ROI through the MMR Stimulus Program; length of sales cycles and the installation process; market acceptance of new product introductions; ability to establish and maintain strategic relationships; ability to identify and integrate acquisitions; relationships with licensees; competitive product offerings and promotions; changes in government laws and regulations and future changes in tax legislation and initiatives in the healthcare industry; undetected errors in our products; possibility of interruption at our data centers; risks related to third party vendors; risks related to obtaining and integrating third-party licensed technology; acceptance of the Company's marketing and promotional campaigns; risks related to a security breach by third parties; maintaining, developing and defending our intellectual property rights including those pertaining to our biotechnology assets; marketing and exploitation of our biotech portfolio; risks associated with recruitment and retention of key personnel; uncertainties associated with doing business internationally across borders and territories; and additional risks discussed in the Company's filings with the Securities and Exchange Commission. Additionally, we are a developing early-stage company and many variables can affect revenues and/or projections, including factors out of our control. The Company is providing this information as of the date of this release and, except as required by law, does not undertake any obligation to update any forward-looking statements contained in this release as a result of new information, future events or otherwise.

CONTACT:



Michael Selsman

Public Communications Co.

(310) 553-5732

ms@publiccommunications.biz

Listen to this $MMRF video very carefully from 4:20 Min on... MMRF market cap is set around $12.38M right now!
http://www.youtube.com/user/MMRGlobalVideos#p/u/11/lz-OBmr_fWQ

MMRF has approx. 4000 shareholders. Hear it from Bobs own lips at Min 5:50 ( http://www.youtube.com/watch?v=lz-OBmr_fWQ ), so it its highly possible that alot of IHUB members already own this stock.

Bob is also working on moving the company to a national exchange ( Min 5:14 )

MMRGlobal Issued Biotech Patent to Produce B-Cell Vaccines and Treat Cancer Patients

LOS ANGELES, CA--(Marketwire -11/28/11)- MMRGlobal, Inc. (OTC.BB: MMRF.OB - News) (www.mmrvideos.com) today announced that it has just been granted a patent protecting methods of making compositions for B-cell vaccines and will soon also have Notice of Allowance for another U.S. Patent protecting "Methods of treating a patient with a B-cell lymphoma." Although technically complex, the patent is a manufacturing patent that covers the methods of making compositions for B-cell vaccines used in the fight against lymphoma and potentially other forms of cancer.

Earlier this month, the Company also filed a continuation application involving similar manufacturing technology in an effort to retain another pending application. Should the application be granted, it would be extremely valuable for a future potential licensee or buyer of the technology. B-cells are the white blood cells that develop from bone marrow and produce antibodies. Common B-cell malignancies for which the patent covers include lymphomas and myelomas, including Non-Hodgkin's Lymphoma.

The Company invested more than $140 million in research and development pertaining to its vaccine trials and use of customized tumor cells to treat lymphoma patients and other technologies. Over the past two years, MMR has been working to license and otherwise exploit an extensive portfolio of biotech assets, which also includes its anti-CD20 monoclonal antibodies, data from vaccine trials, thousands of patient tumor samples and other intellectual property including numerous worldwide patents in various stages.

"MMR acquired this intellectual property and related technology through its reverse merger with Favrille, Inc., a biopharmaceutical company, in January 2009. After nearly two years of diligently identifying these assets, we believe that they could have significant value to our shareholders despite the fact that they were not reflected as an asset on the Company's balance sheet at the time of the merger," said Robert H. Lorsch, MMRGlobal Chairman and Chief Executive Officer.

Although MMRGlobal's primary business is the development and distribution of Health IT products and services based on its patented technologies, including the MyMedicalRecords Personal Health Record (www.mmrvideos.com) and MMRPro, an end-to-end document management and imaging system for physicians, surgery centers and small hospitals which features an integrated patient portal (www.mmrprovideos.com), the Company continues to pursue opportunities to exploit the value of its biotech assets. MMR has already entered into milestone agreements representing license fees of as much as $13 million. The Company believes its data, samples and technology offer value through relationships with biotech investors, universities, and other biotech companies and licensees who might utilize these assets in the development and commercialization of similar cancer fighting vaccines and therapies.

Dendreon's PROVENGE® immunotherapy vaccine, which received FDA approval in April 2010 as the first-of-its-kind cancer treatment to use the body's own immune system to target and attack prostate cancer cells, has generated over $203 million in just over a year, with analysts expecting $372.9 million in revenue in 2012. MMRGlobal's vaccine IP portfolio is also focused on targeted immunotherapies to treat cancer and to work as a customized vaccine made from idiotype protein from a patient's own tumor cells. The Company's Specifid™ vaccine was being created to treat B-cell lymphoma before its trials were ended in 2008.

"More than one hundred million dollars was spent on the creation of the Company's biotech portfolio by investors of pre-merger Favrille. We are doing the best we can to make every effort to see that these assets can someday be incorporated into treatments for individuals living with cancer and other life-threatening diseases," added Lorsch.

About MMRGlobal, Inc.

MMRGlobal, Inc., through its wholly-owned operating subsidiary, MyMedicalRecords, Inc. ("MMR"), provides secure and easy-to-use online Personal Health Records ("PHRs") and electronic safe deposit box storage solutions, serving consumers, healthcare professionals, employers, insurance companies, financial institutions, and professional organizations and affinity groups. The MyMedicalRecords PHR enables individuals and families to access their medical records and other important documents, such as birth certificates, passports, insurance policies and wills, anytime from anywhere using the Internet. MyMedicalRecords is built on proprietary, patented technologies to allow documents, images and voicemail messages to be transmitted and stored in the system using a variety of methods, including fax, phone, or file upload without relying on any specific electronic medical record platform to populate a user's account. The Company's professional offering, MMRPro, is designed to give physicians' offices an easy and cost-effective solution to digitizing paper-based medical records and sharing them with patients in real time through an integrated patient portal. MMR is an Independent Software Vendor Partner with Kodak to deliver an integrated turnkey EMR solution for healthcare professionals. Through its merger with Favrille, Inc. in January 2009, the Company acquired intellectual property biotech assets that include anti-CD20 antibodies and data and samples from its FavId™/Specifid™ vaccine clinical trials for the treatment of B-Cell Non-Hodgkin's lymphoma. To learn more about MMRGlobal, Inc. and its products, visit www.mmrglobal.com.

Forward-Looking Statements

Statements in this press release that are not strictly historical in nature, including statements related to the Company's biotech intellectual property assets and others, future performance, and management's expectations, beliefs, intentions, estimates or projections, constitute "forward-looking statements." Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the Company's actual results to be materially different from historical results or from any results expressed or implied by such forward-looking statements. Some can be identified by the use of words (and their derivations) such as "need," "possibility," "offer," "development," "if," "negotiate," "when," "begun," "believe," "achieve," "will," "estimate," "expect," "maintain," "plan," and "continue," or the negative of these words. Factors that could cause or contribute to such differences include, but are not limited to, the risk the Company's products are not adopted or viewed favorably by the healthcare community and consumer retail market; risks related to the current uncertainty and instability in financial and lending markets, including global economic uncertainties; product integration in physician practices and hospitals; timing and volume of sales and installations; length of sales cycles and the installation process; market acceptance of new product introductions; ability to establish and maintain strategic relationships; ability to identify and integrate acquisitions; relationships with licensees; competitive product offerings and promotions; changes in government laws and regulations and future changes in tax legislation and initiatives in the healthcare industry; undetected errors in our products; possibility of interruption at our data centers; risks related to third party vendors; risks related to obtaining and integrating third-party licensed technology; acceptance of the Company's marketing and promotional campaigns; risks related to a security breach by third parties; maintaining, developing, defending, marketing and licensing our intellectual property rights including those pertaining to our biotechnology assets; the risk and uncertainties inherent in litigation; risks associated with recruitment and retention of key personnel; uncertainties associated with doing business internationally across borders and territories; and additional risks discussed in the Company's filings with the Securities and Exchange Commission. Additionally, we are a developing early-stage company and many variables can affect revenues and/or projections, including factors out of our control. The Company is providing this information as of the date of this release and, except as required by law, does not undertake any obligation to update any forward-looking statements contained in this release as a result of new information, future events or otherwise.
Contact:
CONTACT:
Michael Selsman
Public Communications Co.
(310) 553-5732
ms@publiccommunications.biz

29/11/2011 | Press release
MMRGlobal Shareholder Chat to Be Moderated by International Financial News Host in Town Hall Format

von noodls bereitgestellt am 29/11/2011 15:37

LOS ANGELES, CA, Nov 29, 2011 (MARKETWIRE via COMTEX) --

MMRGlobal, Inc. (OTCBB: MMRF) (www.mmrvideos.com) today announced that as a result of overwhelming response to its shareholder chat scheduled for today, the call will be moderated in a town hall format by financial broadcast executive Donald Baillargeon in order to accommodate an unprecedented number of questions submitted to the Company in advance. The conference call will be broadcast live over the Internet today at 1:15 pm Pacific Time/4:15 p.m. Eastern Time. Individuals interested in participating in the call can access it at phx.corporate-ir.net/...ails&c=178404&eventID=4250082.

Participants should register 15 minutes prior to the start of the Webcast to download any required software. The call may also be accessed by dialing (866)730-5768 with Passcode 89782329 or by linking to Investor Relations at www.mmrglobal.com.

Present on the call will be Chairman/CEO Robert H. Lorsch, Chief Financial Officer Ingrid Safranek and Executive Vice President Richard M. Lagani. Based on questions previously submitted by investors, Mr. Baillargeon will direct questions to Mr. Lorsch, Ms. Safranek or Mr. Lagani. Mr. Baillargeon will also randomly select questions from shareholders during the call for inclusion in the conference.

Mr. Baillargeon is the Founder, Executive Producer and Anchor of MoneyTV, an internationally syndicated business television series which debuted in 1996 and now reaches over 160 million people globally. In the last five years, he has also launched "Health This Week," "MoneyRap Radio," and the "Global Financial News Minute," which is broadcast in the U.S. and Europe in more than 125 million TV households.

About MMRGlobal, Inc.

MMRGlobal, Inc., through its wholly-owned operating subsidiary, MyMedicalRecords, Inc. ("MMR") (www.mymedicalrecords.com), provides secure and easy-to-use online Personal Health Records ("PHRs") and electronic safe deposit box storage solutions, serving consumers, healthcare professionals, employers, insurance companies, financial institutions, and professional organizations and affinity groups. MyMedicalRecords enables individuals and families to access their medical records and other important documents, such as birth certificates, passports, insurance policies and wills, anytime from anywhere using the Internet. The MyMedicalRecords Personal Health Record is built on proprietary, patented technologies to allow documents, images and voicemail messages to be transmitted and stored in the system using a variety of methods, including fax, phone, or file upload without relying on any specific electronic medical record platform to populate a user's account. The Company's professional offering, MMRPro, is designed to give physicians' offices an easy and cost-effective solution to digitizing paper-based medical records and sharing them with patients in real time through an integrated patient portal. MMR is an Independent Software Vendor Partner with Kodak to deliver an integrated turnkey EMR solution for healthcare professionals. Through its merger with Favrille, Inc. in January 2009, the Company acquired intellectual property biotech assets that include anti-CD20 antibodies and data and samples from its FavId(TM)/Specifid(TM) vaccine clinical trials for the treatment of B-Cell Non-Hodgkin's lymphoma. To learn more about MMRGlobal, Inc. and its products, visit www.mmrglobal.com.

Donald Baillargeon has been retained by the Company to moderate the call as an independent moderator and will receive monetary compensation in connection therewith. Mr. Baillargeon is not a representative or affiliate of the Company and is not authorized to speak on the Company's behalf. All opinions and statements made by Mr. Baillargeon during the shareholder call are attributable solely to Mr. Baillargeon and are not the opinions or statements of the Company. Mr. Baillargeon's service as the moderator of the shareholder call does not constitute an endorsement of the Company or its business.

CONTACT:

Michael Selsman
Public Communications Co.
(310) 553-5732
ms@publiccommunications.biz


SOURCE: MMRGlobal, Inc.

mailto:ms@publiccommunications.biz

edge.media-server.com/m/p/8tvpfbb8/lan/en

Presidential Candidate Newt Gingrich says "having a PHR would be a national priority if he became President." Bob Lorsch and MMRF Advisory Board Chairman Hector Barreto have spent more than a year discussing the value of Personal Health Records and the MMRGlobal patented systems with the Presidential Candidate.
twitpic.com/7mdpc7

http://www.youtube.com/watch?v=pbP4FmjyFoc

$MMRF Receives $30 Million Offer for License of Company's Health IT Patent Portfolio

MMRGlobal, Inc. (OTCBB: MMRF) ("MMR"), today announced it has received a proposed agreement from Surgery Center Management, LLC ("SCM") (www.surgerycentermgmt.com) to license certain of the Company's Health Information Technology and Personal Health Record patents for a minimum license fee of $30 million plus additional royalties on terms to be negotiated. Although the offer is subject to the signing of a final definitive licensing agreement, it specifically excludes any of MMRGlobal's biotech assets and other related intellectual property on which the Company has spent more than $100 million in development.

Under the terms of the proposed agreement, MMR would issue a limited non-exclusive, non-transferable, sub-licensable license for its proprietary processes pertaining to the Company's portfolio of Health Information Technology patents. This includes various patents covering proprietary uses of MMR's personal and professional Health IT products and services including its MyMedicalRecords.com Personal Health Record product line for patients (www.mmrvideos.com) and the MMRPro electronic document management and imaging system for physicians, small hospitals and surgery centers (www.mmrprovideos.com). The Company cannot guarantee that a final, legally binding agreement will be reached, however, if completed the agreement would include settlement of any potential claims by MMRGlobal against SCM and its affiliates for any past patent infringement.

In addition to holding numerous patents for Health IT applications, which are already being successfully licensed worldwide, the Company controls a portfolio of biotech assets acquired through a reverse merger with Favrille, Inc. in 2009. Favrille spent more than $100 million in development of certain intellectual property that includes biotech patents and patient samples which MMR is working to license to biotech companies, universities and others. The Company has already demonstrated its ability to license these assets to Big Pharma.

Additional information on the Company's products and services can be found at www.mmrtheater.com and www.mmrglobal.com.

About MMRGlobal, Inc.

MMRGlobal, Inc., through its wholly-owned operating subsidiary, MyMedicalRecords, Inc. ("MMR") (www.mymedicalrecords.com), provides secure and easy-to-use online Personal Health Records ("PHRs") and electronic safe deposit box storage solutions, serving consumers, healthcare professionals, employers, insurance companies, financial institutions, and professional organizations and affinity groups. MyMedicalRecords enables individuals and families to access their medical records and other important documents, such as birth certificates, passports, insurance policies and wills, anytime from anywhere using the Internet. The MyMedicalRecords Personal Health Record is built on proprietary, patented technologies to allow documents, images and voicemail messages to be transmitted and stored in the system using a variety of methods, including fax, phone, or file upload without relying on any specific electronic medical record platform to populate a user's account. The Company's professional offering, MMRPro, is designed to give physicians' offices an easy and cost-effective solution to digitizing paper-based medical records and sharing them with patients in real time through an integrated patient portal. MMR is an Independent Software Vendor Partner with Kodak to deliver an integrated turnkey EMR solution for healthcare professionals. Through its merger with Favrille, Inc. in January 2009, the Company acquired intellectual property biotech assets that include anti-CD20 antibodies and data and samples from its FavId™/Specifid™ vaccine clinical trials for the treatment of B-Cell Non-Hodgkin's lymphoma. To learn more about MMRGlobal, Inc. and its products, visit www.mmrglobal.com.

Forward-Looking Statements

All statements in this press release that are not strictly historical in nature, whether or not such statement relates directly to the proposed agreement from Surgery Center Management, LLC or the terms contained therein, and the Company's future performance, management's expectations, beliefs, intentions, estimates or projections, constitute "forward-looking statements." Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the Company's actual results to be materially different from historical results or from any results expressed or implied by such forward-looking statements. Some can be identified by the use of words (and their derivations) such as "need," "possibility," "offer," "development," "if," "negotiate," "when," "begun," "believe," "achieve," "will," "estimate," "expect," "maintain," "plan," and "continue," or the negative of these words. Factors that could cause or contribute to such differences include, but are not limited to, the risk that the Company and Surgery Center Management, LLC will not reach a definitive agreement with respect to the proposed license agreement and any contemplated transactions therein, and even if consummated, the Company cannot guarantee the terms of such agreement, once consummated, will be favorable to the Company and/or its stockholders; the risk the Company's products are not adopted or viewed favorably by the healthcare community; risks related to the current uncertainty and instability in financial and lending markets, including global economic uncertainties; financial projections; product integration in physician practices, surgery centers and hospitals; timing and volume of sales and installations; length of sales cycles and the installation process; market acceptance of new product introductions; ability to establish and maintain strategic relationships; ability to identify and integrate acquisitions; relationships with licensees; competitive product offerings and promotions; changes in government laws and regulations, especially as related to the healthcare industry; future changes in tax legislation and initiatives and exposure to additional tax liabilities; undetected errors in our products; possibility of interruption at our data centers; risks related to third party vendors; risks related to obtaining and integrating third-party licensed technology; current and future litigation; acceptance of the Company's marketing and promotional campaigns; the value of the Company's broadcasting advertising and sponsorships; negotiated milestone payments; risks related to a security breach by third parties; maintaining, developing and defending our intellectual property rights including those pertaining to our biotechnology assets; risks associated with recruitment and retention of key personnel; uncertainties associated with doing business internationally across borders and territories; and additional risks discussed in the Company's filings with the Securities and Exchange Commission. Additionally, we are a developing early-stage company and many variables can affect revenues and/or projections, including factors out of our control. The Company is providing this information as of the date of this release and, except as required by law, does not undertake any obligation to update any forward-looking statements contained in this release as a result of new information, future events or otherwise. You are cautioned not to place undue reliance on the forward-looking statements set forth in this press release.

CONTACT:



Michael Selsman

Public Communications Co.

(310) 553-5732

ms@publiccommunications.biz

Market Cap beläuft sich aktuell auf $13.12M.
MMRF ist somit krass unterbewertet!

Tageshoch liegt aktuell bei $0.064

Schlußralley kommt ! Aktueller Kurs $0.052 x $0.056

nächste Kursziele: $0.65 , $0.75 , $0.10.
Persönlich glaube ich dass MMRF noch in diesem Monat mindestens $0.15 sehen wird.

Die $30 million Gebühr ist ein Minimum Gebot für die Lizenzrechte ohne eingerechnete Royalties, die an MMRF bezahlt werden müssen.
MMRF hat aktuell bei $0.056 mit einer Market Cap von nur 18.83M bewertet!
Der faire Wert ist mit diesem Deal erst einmal bei $0.09 anzusiedeln, wenn man alles andere von MMRF an Geschäft außenvorläßt.

****Recent News from MMR Global**** (includes ALL MoneyTV Interviews)

12/7/11 MMRGlobal Receives $30 Million Offer for License of Company's Health IT Patent Portfolio
MMR announced it has received a proposed agreement from Surgery Center Management, LLC ("SCM") (www.surgerycentermgmt.com) to license certain of the Company's Health Information Technology and Personal Health Record patents for a minimum license fee of $30 million plus additional royalties on terms to be negotiated.
investorshub.advfn.com/boards/read_msg.aspx?message_id=69677689

12/5/11 MMRGlobal Discusses M&A Strategy in Conference Call With Shareholders
In a conference call with shareholders last week, MMR discussed its strategy to identify transactions with large privately held companies in healthcare, health IT and revenue cycle management that have expressed interest in becoming publicly traded. MMR previously reported the existence of a non-binding term sheet with a company in which negotiations are taking place. MMR is also pursuing other existing opportunities at the same time to ensure that any transaction will be the best one available for its shareholders.
ih.advfn.com/p.php?pid=nmona&article=50304564

11/28/11 MMRGlobal Issued Biotech Patent to Produce B-Cell Vaccines and Treat Cancer Patients
MMR announced that it has just been granted a patent protecting methods of making compositions for B-cell vaccines and will soon also have Notice of Allowance for another U.S. Patent protecting "Methods of treating a patient with a B-cell lymphoma."
ih.advfn.com/p.php?pid=nmona&article=50205520

11/16/11 MMRGlobal Joins ng Connect Program
MMR's MyMedicalRecords Personal Health Record will also be included as part of a new ng Connect service concept to be featured at the 2012 Consumer Electronics Show, January 10-13, 2012, Las Vegas, NV, Booth #31412 in the South Upper Hall.
ih.advfn.com/p.php?pid=nmona&article=50057969

11/14/11 MMRGlobal Reports 113% Increase in Third Quarter Revenue
The Company reported an increase in revenues of 96% for the nine-month period ended September 30, 2011 over the same period in 2010, and a 113% increase in revenues over the second quarter in 2011.
ih.advfn.com/p.php?pid=nmona&article=49941821

11/4/11 MMRGlobal Retains The MichaelBass Group for Healthcare IT Valuation and Banking Relationship Expertise
MMRF announced that it has retained The MichaelBass Group (MBG) to provide valuation expertise and help the Company identify investment bankers and analysts for a potential transaction combining revenue cycle management, health IT, document management and imaging services for healthcare professionals, patient care, and the exploitation of biotech assets into one consolidated entity.
ih.advfn.com/p.php?pid=nmona&article=49792554

10/25/11 MMRGlobal and REACH Air Medical Services Partner to Add MyMedicalRecords PHR to Emergency Helicopter and Airplane Evacuation
MMRF announced they have signed an agreement to offer MMR's signature MyMedicalRecords PHR to all of REACH's current and future clients and customers.The company has approximately 15,000 members in its REACH for Life membership program which will be offered the Personal Health Record service.
ih.advfn.com/p.php?pid=nmona&article=49658931

10/17/11 MMRGlobal Enters Into Agreement With UST Global(R) to Offer Personal Health Records and Launch Pre-Paid PHR at Retail
MMR Global will offer its PHR to UST Global's clients and strategic partners. MMR is also providing 1,500 UST employees in the U.S. PHRs under the company's employee benefit program. In addition, the two companies will create a pre-paid Personal Health Record card to be offered for sale at pharmacy retailers and other mass merchandisers starting in the United States.
ih.advfn.com/p.php?pid=nmona&article=49561529

10/12/11 Mike Finley Joins MMRGlobal Board of Directors, Analyst Picks MMRGlobal as "Stock to Watch"
Mike Finley, Vice President, Worldwide Carrier Relations for Qualcomm, has joined the Company's Board of Directors, the same week The Institute for Health Technology Transformation released that MMRGlobal was selected as the "Stock to Watch" at the annual iHT2 Health Technology Innovation & Investment Forum
ih.advfn.com/p.php?pid=nmona&article=49511332

10/10/11 MMRGlobal on the Move Through the Middle East, China
To facilitate plans to go to Qatar, the Company also recently entered into an agreement with The ICA Group to assist in sales and marketing throughout the Middle East and in parts of Russia. The ICA Group was introduced to the Company by Chartis whom it also has represented.
ih.advfn.com/p.php?pid=nmona&article=49480279

9/19/11 MMRGlobal Signs Definitive Agreements With 13 Surgery Centers Potentially Representing Millions of Dollars in Recurring Revenue
The relationship with JER also represents the first step of integrating MMR products and services into other JER clients and 1-800-GET-THIN. Delivery of approximately $400,000 of the installations will begin immediately and is estimated to be completed early in the fourth quarter.
ih.advfn.com/p.php?pid=nmona&article=49222553

9/7/11 MMRGlobal Enters Into Agreement With Private Healthcare Revenue Cycle Management Group
Based on representations in the term sheet if completed, MMR believes that JER could represent more than 150 million dollars in revenues to MMR following the signing of the final definitive agreement.
ih.advfn.com/p.php?pid=nmona&article=49087121

8/24/11 Earthquake Preparedness Expert and MMRGlobal CEO Bob Lorsch Offers Disaster Preparedness Booklets Online in the Wake of East Coast Hurricane Irene
ih.advfn.com/p.php?pid=nmona&article=48934127

8/15/11 MMRGlobal Reports 158% Increase in Year-to-Date Revenue
The Company reported revenues for the six-month period ended June 30, 2011 of $737,618, or 158% of the previously reported revenue for the same period in 2010. Although revenues were impacted by the delay in the signing of the Private Label agreement with Kodak (EK:$2.1500,$0.0800,3.86%) , they were still $451,357 or 158% higher as compared to the first six months of 2010
investorshub.advfn.com/boards/read_msg.aspx?message_id=66202389

8/11/11 MMRGlobal Invites Shareholders to Sneak Peek "Eat on Us" Campaign and to Participate in Investor Call
announced a sneak peek at its "Eat on Us" direct-to-consumer campaign at phr.mmrcontent.com/sneakpeek/
ih.advfn.com/p.php?pid=nmona&article=48793344

8/5/11 MMRGlobal Announces Private Label Agreement With MediSwipe to Offer Personal Health Records
The Company has entered into an agreement with MediSwipe, Inc. to private label MyMedicalRecords.com to tens of thousands of patients through MediSwipe pharmacies, wellness and medical centers.
ih.advfn.com/p.php?pid=nmona&article=48776733

8/4/11 MMRGlobal Stimulus Program Available to All Health Care Professionals Including Surgery and Weight Loss Centers
The program enables health care professionals to generate unlimited MMR stimulus money, which can easily be many times greater than programs offered by the government that go up to $44,000 over a five-year period of time.
ih.advfn.com/p.php?pid=nmona&article=48698092

8/1/11 MMRGlobal Recovers Biotech Assets and Files Liquidated Damages Claim Against Reality Television Stars Taylor and Russell Armstrong
MMRF today announced that it has recovered more than 1,000 biological samples from defendants in a lawsuit brought last year by The RHL Group Inc. The Company also announced that it filed a complaint against reality television stars Taylor Ford Armstrong and Russell Lynn Armstrong as well as NuWay Digital Systems, Inc. and others (the Armstrongs), seeking liquidated damages of $1,500,000 plus any additional claims for $250,000 each that could surface during the litigation.
ih.advfn.com/p.php?pid=nmona&article=48641741

7/25/11 Kodak and MMRGlobal Sign Private Label Equipment Purchase Agreement
The agreement calls for MMRGlobal to purchase a minimum of 135 MMRPro-ready Scan Station Pro 550's representing approximately three million dollars in MMRPro system sales over the initial term plus the potential of millions more in MMRPro Stimulus Program revenue over additional years.
ih.advfn.com/p.php?pid=nmona&article=48557402

7/21/11 MMRGlobal Announces Agreement for Four Million Warrants at Market Premium by Chinese Investment Partner
Unis-Tonghe has the right to purchase up to four (4) million shares of the Company's common stock: one million at 8 cents per share, an additional million shares at 12 cents per share, an additional million at 16 cents per share, and one million at 20 cents per share.
ih.advfn.com/p.php?pid=nmona&article=48524156

7/14/11 MoneyTV to Air Coverage on MMRGlobal
ALL Money TV Interviews- Link Below(updated 12/9/11)
investorshub.advfn.com/boards/read_msg.aspx?message_id=69795006

7/6/11 Kodak and 4medica Combine EHR Clinical Integration and Document Scanning to Benefit Providers
4medica is working with MMRGlobal (MMRF) to incorporate the MMR Personal Health Record (PHR) into 4medica products and services. MMR's PHR software, together with 4medica and Kodak's document imaging solutions, will improve patients' access to medical-related information. Kodak and MMRGlobal continue to work with other developers to streamline the exchange of information between health care providers and their patients.
investorshub.advfn.com/boards/read_msg.aspx?message_id=64925347

7/5/2011 MMRGlobal, Inc. Finds Enormous Distribution Channel with Wireless Reseller PCS International
With a massive load out of over 120k customer accounts, PCS is a service provider with the capacity to bring the products immediately to select clients in businesses that can use the MMRPro document management and imaging system, businesses ranging from healthcare providers and other hospitals/clinics, to law firms and accountants. A dedicated team of fourteen top sales executives stand poised to marshal an army of over 50 field sales reps at the designated retail locations, ready for the volume of business to business sales this move will no doubt provoke from the market.
investorshub.advfn.com/boards/read_msg.aspx?message_id=64892617

6/27/11 MMRGlobal Becoming Odds-On Favorite to Win Personal Health Records Race
MMRGlobal, Inc. today announced that following the impending closing of Google Health, MyMedicalRecords, the Company's consumer Personal Health Record (PHR), stands alone as the single easiest to access and use, secure, multilingual PHR with more than 700,000 members.
investorshub.advfn.com/boards/read_msg.aspx?message_id=64640055

6/22/11 MMRGlobal Joint Venture Partner Unis-Tonghe Wins Bid in China
Unis will deploy the Unis Medical Clouds Service throughout the Province which will be purchased by the Henan Province Government's Department of Public Health.
They are a winner of a bid to provide eHealth and Electronic Medical Record Services of 164 County/District of Henan Province in China. Henan Province is one of the largest provinces in China with nearly 100 million citizens.
investorshub.advfn.com/boards/read_msg.aspx?message_id=64491293

6/16/11 MMRGlobal and VisiInc PLC Announce License Agreement and Exchange of Equity in Connection With New eHealth Product Pipeline
MMR will grant to VisiInc an exclusive license to its proprietary eHealth patent portfolio in Australia with additional rights in certain areas of Eastern Europe. As partial additional consideration for the granting of the patents, VisiInc has granted one million warrants to MMR and MMRGlobal has granted one million warrants to VisiInc.
investorshub.advfn.com/boards/read_msg.aspx?message_id=64299008

6/8/11 MMRGlobal, Inc. Announces Initiated Coverage from BUYINS.NET
The total aggregate number of shares shorted since August 2009 is approximately 59.73 million shares. Approximately 41.10% of daily trading volume is short selling. The SqueezeTrigger price for all MMRF (OTCBB: MMRF) shares shorted is $.1321. The first of several short squeezes is expected to begin above $.0597, where approximately 4.34 million shares have previously been shorted between $.0301 and $.0597.
investorshub.advfn.com/boards/read_msg.aspx?message_id=64007331

6/1/11 VisiInc PLC and MMRGlobal Announce Agreement to Launch MyMedicalRecords Personal Health Record on Vistime Platform Throughout Australia
VisiInc PLC (www.deutsche-boerse.com) have entered into an agreement to launch MMRGlobal's (MMRF:$0.04,00$0.00,000.00%) patented consumer and professional health IT products and services, including MMRPro for healthcare professionals (www.mmrprovideos.com) and the MyMedicalRecords Personal Health Record (PHR) (www.mmrvideos.com), on the Visi? platform utilizing the Vistime product. Initially, the two companies will collaborate on offering products and services jointly to the health technology market in Australia, which is currently projected to be as much as $2.4 billion this year.
investorshub.advfn.com/boards/read_msg.aspx?message_id=63756582

5/31/11 Interbit Data and MMRGlobal to Offer Personal Health Records in Advance of Meaningful Use Requirement
"Interbit Data provides service to more than 600 hospitals, which will provide MMRGlobal a major opportunity to touch millions of patients through the point of care. The partnership between MMRGlobal and Interbit Data will allow more patients to gain greater control over their health and well-being and better prepare their families for an emergency while providing a revenue opportunity for providers.
investorshub.advfn.com/boards/read_msg.aspx?message_id=63723802

5/24/11 MMRGlobal Announces Renewal of RHL Group Credit Line
The RHL Group, Inc., a corporation owned by Robert H. Lorsch, the Chairman, President and Chief Executive Officer of MMRGlobal and one of the Company's largest shareholders, has agreed to renew MMR's current three million dollar credit line.
ih.advfn.com/p.php?pid=nmona&article=47805865

5/16/11 MMRGlobal Reports Record Revenue Increase
The Company reported revenues for the quarter ended March 31, 2011 of $571,981 or 634% of the previously reported revenue for the first quarter of 2010. Revenues increased by $481,817 or 534% as compared to the first quarter of 2010.
ih.advfn.com/p.php?pid=nmona&article=47699888

5/9/11 MMRGlobal Technology Partner Acquires 13 Million Shares at More Than 30% Above Market
Nihilent Technologies, Inc. has acquired 13 million restricted Rule 144 shares of MMRGlobal at a value of more than thirty percent (30%) above market price.
ih.advfn.com/p.php?pid=nmona&article=47586280

5/2/11 MMRGlobal and Alcatel-Lucent Enable Patients to Upload Monitored Vital Signs Directly Into MyMedicalRecords Personal Health Records
("MMR") today announced that it is working with Alcatel-Lucent to integrate the MyMedicalRecords Personal Health Record with Alcatel-Lucent's TeleHealth Manager solution to simplify the collection and notification of vital health records.
ih.advfn.com/p.php?pid=nmona&article=47486970

4/25/11 MMRGlobal to Participate at Microsoft(R) Connected Health Conference While Joining Forces With First Lady Michelle Obama and Dr. Jill Biden
CEO Robert H. Lorsch will be in Chicago this week as part of the Company's plans to introduce its patented MyMedicalRecords Personal Health Record products and services and MMRPro professional document imaging solution demonstrated on the new Kodak Scan Station 550 to hospital administrators, physicians, policymakers and wellness solution providers attending the Microsoft® Connected Health Conference.
ih.advfn.com/p.php?pid=nmona&article=47405924

4/18/11 MMRGlobal Announces Plans to Build Branded Document Delivery and Tracking Solution for Banks and Financial Institutions
Approximately four years ago, the Company began working with representatives from Countrywide Financial to speed up processing and delivery of loan documents in lieu of traditional systems, such as overnight courier services, at substantially less cost. The rollout was delayed by the acquisition of Countrywide by Bank of America. The Company projects a beta test of the product later this year and will now begin offering similar programs industry wide.
ih.advfn.com/p.php?pid=nmona&article=47333935

Charlie Bragg, world renowned artist, at MMRGlobal’s Corporate Global Training Center to sign Chartis Collectable Cannisters featuring the artist’s works, hours before MMR did its own signing of a $30 million dollar license Agreement to be announced Monday morning.
a1.sphotos.ak.fbcdn.net/hphotos-ak-snc7/...77_914545395_n.jpg" style="max-width:560px" />

MMRF Signs $30 Million Non-Exclusive Patent License Agreement

MMRGlobal, Inc. (OTCBB: MMRF) ("MMR") (the "Company") today announced that on December 9, 2011 it signed a Settlement and Patent License Agreement (the "Agreement") with Surgery Center Management LLC ("SCM") to license certain of the Company's Health IT and Personal Health Record patents, including various patents covering uses of MMR's personal and professional Health IT products and services. These include the Company's MyMedicalRecords.com (www.mmrvideos.com) Personal Health Record and MMRPro (www.mmrprovideos.com) document imaging and scanning solutions for healthcare professionals (the "Licensed Patents") for a payment of $30 million plus additional usage royalties as outlined in the Agreement. The Agreement specifically excludes any of MMRGlobal's biotech assets.

Under the terms of the Agreement, MMR shall issue a limited, non-exclusive, non-transferable license to the Licensed Patents which cover the Licensed Products and/or Licensed Services to develop, make, have made, use, sell, lease, license, demonstrate, market and distribute the Licensed Products and/or Licensed Services under Licensee's brand, or private labeled for channel or distribution partners who purchase the Licensed Products and/or Licensed Services for resale to end customers. The Licensed Patents shall mean any issued or pending U.S. and/or foreign patent applications and/or issued patents including but not necessarily limited to Singapore, Hong Kong, Israel, South Korea, Mexico, New Zealand, Canada, Germany, Japan, United Kingdom, and the United States. The Agreement includes settlement of any potential claims by MMRGlobal against SCM and its affiliates for any past patent infringement.

"Last year, MMRGlobal celebrated the New Year by announcing a $13 million biotech licensing agreement. This year, MMR will go into the New Year announcing a $30 million licensing agreement. These license agreements highlight the potential value in the Company's patents and other Intellectual Property," said Robert H. Lorsch, Chairman and CEO of MMRGlobal.

The Agreement also contains customary provisions for this type of Agreement, such as the term of the Agreement, terms for payment, warranties and representations of the parties, and indemnities by the Company and SCM to each other. Although the effective date of the Agreement is December 9th, certain material rights and releases contained in the Agreement require that SCM pay the entire $30 million to MMR before those rights and releases become effective without which MMRGlobal would not have entered into the Agreement. The Company intends to file the Agreement as an exhibit to the Company's Annual Report on Form 10K.

In addition to holding numerous patents for Health IT applications, which are already being successfully licensed worldwide, the Company controls a portfolio of biotech assets acquired through a reverse merger with Favrille, Inc. in 2009. Favrille spent more than $100 million in development of certain intellectual property that includes biotech patents and patient samples, which MMR is working to license to biotech companies, universities and others. As previously reported, the Company has already demonstrated its ability to license portions of these biotech assets.

About MMRGlobal, Inc.

MMRGlobal, Inc., through its wholly-owned operating subsidiary, MyMedicalRecords, Inc. ("MMR") (www.mymedicalrecords.com), provides secure and easy-to-use online Personal Health Records ("PHRs") and electronic safe deposit box storage solutions, serving consumers, healthcare professionals, employers, insurance companies, financial institutions, and professional organizations and affinity groups. MyMedicalRecords enables individuals and families to access their medical records and other important documents, such as birth certificates, passports, insurance policies and wills, anytime from anywhere using the Internet. The MyMedicalRecords Personal Health Record is built on proprietary, patented technologies to allow documents, images and voicemail messages to be transmitted and stored in the system using a variety of methods, including fax, phone, or file upload without relying on any specific electronic medical record platform to populate a user's account. The Company's professional offering, MMRPro, is designed to give physicians' offices an easy and cost-effective solution to digitizing paper-based medical records and sharing them with patients in real time through an integrated patient portal. MMR is an Independent Software Vendor Partner with Kodak to deliver an integrated turnkey EMR solution for healthcare professionals. Through its merger with Favrille, Inc. in January 2009, the Company acquired intellectual property biotech assets that include anti-CD20 antibodies and data and samples from its FavId™/Specifid™ vaccine clinical trials for the treatment of B-Cell Non-Hodgkin's lymphoma. To learn more about MMRGlobal, Inc. and its products, visit www.mmrglobal.com.

Forward-Looking Statements

All statements in this press release that are not strictly historical in nature, whether or not such statement relates directly to the Agreement between MMRGlobal, Inc. and Surgery Center Management, LLC signed on December 9, 2011 or the terms contained therein, and the Company's future performance, management's expectations, beliefs, intentions, estimates or projections, constitute "forward-looking statements." Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the Company's actual results to be materially different from historical results or from any results expressed or implied by such forward-looking statements. Some can be identified by the use of words (and their derivations) such as "need," "possibility," "offer," "development," "if," "negotiate," "when," "begun," "believe," "achieve," "will," "estimate," "expect," "maintain," "plan," and "continue," or the negative of these words. Factors that could cause or contribute to such differences include, but are not limited to, the risk that Surgery Center Management, LLC could terminate the Settlement and Patent License Agreement as a result of any inability on the part of the Company to perform any of its obligations under the Agreement or any legal or regulatory matters affecting SCM's ability to utilize any portion of the Licensed Patents. The Company is providing this information as of the date of this release and, except as required by law, does not undertake any obligation to update any forward-looking statements contained in this release as a result of new information, future events or otherwise. You are cautioned not to place undue reliance on the forward-looking statements set forth in this press release.

CONTACT:



Michael Selsman

Public Communications Co.

(310) 553-5732

ms@publiccommunications.biz

Tageshoch $0.065
Tagestief $0.055
Aktueller Kurs $0.0574

JER has also represented to MMR that they are in the business of, amongst other things, purchasing medical and Workman's compensation insurance accounts receivable and plans to continue to do so on an ongoing basis in addition to the business of MMR. JER currently has at least $150,000,000 in accounts receivable, which would be contributed to MMR on closing of the Transaction.

Reconstructive is a Health IT company that has represented to MMR to have its own proprietary patent pending electronic health records ("EHR") and practice management software. Reconstructive has annual gross revenues under generally accepted accounting principles in 2010 of approximately $8,000,000 and EBITDA of approximately $3,500,000, and comparable or better annual gross revenues and EBITDA for 2011.

JER and Reconstructive have represented to MMR that together they are in the revenue cycle management business that automates and manages billing-related functions for physician practices assisting them with the handling of claims and billing processes to help manage reimbursement and includes a practice management platform.

JER and Reconstructive at a minimum will transfer all of the assets described above including but not limited to all of its business, goodwill, real property, accounts, assets, tangible and intangible personal property, all ownership interests in its business and assets, including stock, or property to which it has a right to acquire in the future, to MMR in exchange for the issuance of preferred stock of MMR (the "Preferred Stock"), with the terms of such Preferred Stock to be negotiated between the parties (the "Transaction"). The Preferred Stock is intended to represent a fair portion of MMR's equity as determined by one or more independent investment banking firms.

2

The Transaction and its final structure is subject to a number of conditions and contingencies, including, but not limited to, independent valuations and a fairness opinion by a top tier investment banking firm selected by MMR, as well as the negotiation and acceptance of a definitive Merger Agreement or Asset Purchase Agreement (as to be determined after discussion with the parties respective tax, legal and financial advisors), a final audit of JER and Reconstructive, satisfactory completion of due diligence and the receipt of corporate approvals for the Transaction to the extent required therefor.

JER and Reconstructive have also agreed to pay all outstanding balances under MMR's credit line with The RHL Group and to immediately replace such credit line with a substantially similar JER and Reconstructive credit line upon execution of the Memorandum.

On closing the Company will operate under the name of MMRGlobal. The parties plan on Robert Lorsch remaining as Chief Executive Officer after the closing of the Transaction.

The parties have agreed to use their best efforts to close the transaction as soon as reasonable possible given the time for audits, fairness opinions due diligence, proxies and other SEC filings to the extent necessary.